Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Clin Immunol ; 235: 108930, 2022 02.
Artigo em Inglês | MEDLINE | ID: mdl-35063669

RESUMO

We report a female patient presenting with generalized pustular psoriasis and hypogammaglobulinemia due to digenic mutations in IL-36RA and SEC61A1. The patient presented with recurrent fevers, elevated inflammatory markers, hepatosplenomegaly, and recurrent sinopulmonary infections in the context of hypogammaglobulinemia which improved on immunoglobulin replacement. This report demonstrates how digenic inheritance leads to complex phenotypes, and illustrates the importance of following an unbiased approach to identifying variants, especially in patients with atypical clinical presentations.


Assuntos
Agamaglobulinemia/genética , Predisposição Genética para Doença , Interleucinas/genética , Psoríase/genética , Canais de Translocação SEC/genética , Agamaglobulinemia/patologia , Pré-Escolar , Consanguinidade , Feminino , Humanos , Mutação , Linhagem , Psoríase/patologia
2.
Clin Immunol ; 244: 109131, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36179983

RESUMO

Monogenic immune dysregulation diseases (MIDD) are caused by defective immunotolerance. This study was designed to increase knowledge on the prevalence and spectrum of MIDDs, genetic patterns, and outcomes in Middle East and North Africa (MENA). MIDD patients from 11 MENA countries (Iran, Turkey, Kuwait, Oman, Algeria, Egypt, United Arab Emirates, Tunisia, Jordan, Qatar, and Azerbaijan) were retrospectively evaluated. 343 MIDD patients (58% males and 42% female) at a median (IQR) age of 101 (42-192) months were enrolled. The most common defective genes were LRBA (23.9%), LYST (8.2%), and RAB27A (7.9%). The most prevalent initial and overall manifestations were infections (32.2% and 75.1%), autoimmunity (18.6% and 41%), and organomegaly (13.3% and 53.8%), respectively. Treatments included immunoglobulin replacement therapy (53%), hematopoietic stem cell transplantation (HSCT) (14.3%), immunosuppressives (36.7%), and surgery (3.5%). Twenty-nine (59.2%) patients survived HSCT. Along with infectious complications, autoimmunity and organomegaly may be the initial or predominant manifestations of MIDD.


Assuntos
Doenças da Imunodeficiência Primária , Proteínas Adaptadoras de Transdução de Sinal/genética , Adolescente , Criança , Pré-Escolar , Egito , Feminino , Humanos , Masculino , Doenças da Imunodeficiência Primária/genética , Sistema de Registros , Estudos Retrospectivos , Tunísia , Turquia , Proteínas de Transporte Vesicular/genética , Proteínas rab27 de Ligação ao GTP/genética
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa